专题：Neuroblastoma Research and Treatments

This cluster of papers represents a comprehensive exploration of neuroblastoma, covering topics such as genetic mutations (including ALK and MYCN), risk classification, staging systems, immunotherapy, and genomic analysis. The research also delves into therapy strategies and prognosis for patients with neuroblastoma.
最新文献
Bone niches in the regulation of tumour cell dormancy

article Full Text OpenAlex

Immune Checkpoint Inhibitors for Pediatric Cancers: Is It Still a Stalemate?

review Full Text OpenAlex

Pegylated liposomal doxorubicin combined with cyclophosphamide and vincristine in pediatric patients with relapsed/refractory solid tumor: a single-arm, open-label, phase I study

article Full Text OpenAlex

DOK7 congenital myasthenic syndrome: case series and review of literature

article Full Text OpenAlex

Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors

article Full Text OpenAlex

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

review Full Text OpenAlex

A novel hydrophobic tag leads to the efficient degradation of programmed death-ligand 1

article Full Text OpenAlex

Characterization of Clinical Phenotypes in Congenital Myasthenic Syndrome Associated with the c.1327delG Frameshift Mutation in CHRNE Encoding the Acetylcholine Receptor Epsilon Subunit

article Full Text OpenAlex

Antitumor Activity of a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma

article Full Text OpenAlex

Clinicopathologic characteristics and prognostic factors of patients with surgically treated high‐grade neuroendocrine carcinoma of the cervix: A multicenter retrospective study

article Full Text OpenAlex

近5年高被引文献
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

review Full Text OpenAlex 10245 FWCI1476.20840378

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015–2019

article Full Text OpenAlex 1287 FWCI291.61741519

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016—2020

article Full Text OpenAlex 939 FWCI318.20291138

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

review Full Text OpenAlex 809 FWCI181.33265954

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 516 FWCI100.43412153

177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial

article Full Text OpenAlex 459 FWCI58.05709765

GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma

article Full Text OpenAlex 434 FWCI102.87951249

Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group

article Full Text OpenAlex 405 FWCI40.84383277

Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system

review Full Text OpenAlex 349 FWCI50.91623438

Endocrine toxicities of immune checkpoint inhibitors

review Full Text OpenAlex 344 FWCI26.62719937